Eikonizo Therapeutics

Developer of small-molecule therapeutic drugs designed to treat neurodegenerative disease. The company employs various gene therapy techniques, including viral vectors, to deliver corrected genes or g...

Healthcare
Cambridge, MA, United States
Founded 2017
10 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$46.1M
Last Round
N/A

Get the full picture

Create a free account to unlock Eikonizo Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required